MARKET

ALVO

ALVO

Alvotech
NASDAQ
3.680
+0.200
+5.75%
After Hours: 3.740 +0.06 +1.63% 18:15 06/26 EDT
OPEN
3.560
PREV CLOSE
3.480
HIGH
3.700
LOW
3.485
VOLUME
991.87K
TURNOVER
--
52 WEEK HIGH
9.94
52 WEEK LOW
2.940
MARKET CAP
1.23B
P/E (TTM)
-13.1054
1D
5D
1M
3M
1Y
5Y
1D
Transactions of Managers and Closely Associated Persons
Barchart · 6d ago
Weekly Report: what happened at ALVO last week (0615-0619)?
Weekly Report · 6d ago
Alvotech Raises $165 Million Through Share Offering and Concurrent Private Placement
TipRanks · 06/18 16:57
Alvotech prices 26,066,667-share follow-on offering at $3.75 each, raising $98 million gross
PUBT · 06/18 08:01
ALVOTECH ANNOUNCES PROPOSED $125 MILLION PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT OF ORDINARY SHARES
Reuters · 06/18 08:00
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement
Barchart · 06/18 03:00
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
Barchart · 06/18 03:00
Alvotech Raises Over $150 Million in U.S. Equity Offering and European PIPE as It Resubmits Key Biosimilar BLAs
TipRanks · 06/17 10:32
More
About ALVO
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVO stock methods without spending real money on the virtual paper trading platform.